Cite
MLA Citation
R. Brik et al.. “OP0075 A 6-Month, Phase 2, Open–Label, Single-Arm Study to Evaluate the Safety and Efficacy of Treatment with Canakinumab of Pediatric Patients with Colchicine Resistant Familial Mediterranean Fever.” Annals of the rheumatic diseases, vol. 72, 2013, pp. A75–A76. http://access.bl.uk/ark:/81055/vdc_100137783600.0x00005d